A citation-based method for searching scientific literature

Amanda M Vanderplow, Andrew L Eagle, Bailey A Kermath, Kathryn J Bjornson, Alfred J Robison, Michael E Cahill. Neuron 2021
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex.
Helena M Abelaira, Gislaine Z Réus, Zuleide M Ignácio, Maria Augusta B Dos Santos, Airam B de Moura, Danyela Matos, Júlia P Demo, Júlia B I da Silva, Monique Michels, Mariane Abatti,[...]. J Psychiatr Res 2017
24
33

Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.
Mark J Millan, Yves Agid, Martin Brüne, Edward T Bullmore, Cameron S Carter, Nicola S Clayton, Richard Connor, Sabrina Davis, Bill Deakin, Robert J DeRubeis,[...]. Nat Rev Drug Discov 2012
635
33

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin.
Chadi G Abdallah, Lynnette A Averill, Ralitza Gueorguieva, Selin Goktas, Prerana Purohit, Mohini Ranganathan, Mohamed Sherif, Kyung-Heup Ahn, Deepak Cyril D'Souza, Richard Formica,[...]. Neuropsychopharmacology 2020
47
33

Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade.
Kenneth Maiese, Zhao Zhong Chong, Shaohui Wang, Yan Chen Shang. Int J Mol Sci 2012
71
33

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
33

New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.
Zuleide M Ignácio, Gislaine Z Réus, Camila O Arent, Helena M Abelaira, Meagan R Pitcher, João Quevedo. Br J Clin Pharmacol 2016
69
33

mTOR complexes in neurodevelopmental and neuropsychiatric disorders.
Mauro Costa-Mattioli, Lisa M Monteggia. Nat Neurosci 2013
204
33


De novo missense variants in PPP2R5D are associated with intellectual disability, macrocephaly, hypotonia, and autism.
Linshan Shang, Lindsay B Henderson, Megan T Cho, Donald S Petrey, Chin-To Fong, Katrina M Haude, Natasha Shur, Julie Lundberg, Natalie Hauser, Jason Carmichael,[...]. Neurogenetics 2016
31
33

Prolyl oligopeptidase: a potential target for the treatment of cognitive disorders.
Pekka T Männisto, Jarkko Venäläinen, Aaro Jalkanen, J Arturo García-Horsman. Drug News Perspect 2007
89
33


Deficiency of prolyl oligopeptidase in mice disturbs synaptic plasticity and reduces anxiety-like behaviour, body weight, and brain volume.
Corinna Höfling, Natalia Kulesskaya, Külli Jaako, Iida Peltonen, Pekka T Männistö, Antti Nurmi, Nina Vartiainen, Markus Morawski, Alexander Zharkovsky, Vootele Võikar,[...]. Eur Neuropsychopharmacol 2016
21
33

Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition.
Ingo Schulz, Bernd Gerhartz, Antje Neubauer, Andreas Holloschi, Ulrich Heiser, Mathias Hafner, Hans-Ulrich Demuth. Eur J Biochem 2002
95
33

Beneficial effect of prolyl oligopeptidase inhibition on spatial memory in young but not in old scopolamine-treated rats.
Aaro J Jalkanen, Katja A Puttonen, Jarkko I Venäläinen, Veijo Sinervä, Anne Mannila, Sirja Ruotsalainen, Elina M Jarho, Erik A A Wallén, Pekka T Männistö. Basic Clin Pharmacol Toxicol 2007
37
33

PDE11A negatively regulates lithium responsivity.
G Pathak, M J Agostino, K Bishara, W R Capell, J L Fisher, S Hegde, B A Ibrahim, K Pilarzyk, C Sabin, T Tuczkewycz,[...]. Mol Psychiatry 2017
15
33

Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo.
Reinis Svarcbahs, Ulrika H Julku, Susanna Norrbacka, Timo T Myöhänen. Sci Rep 2018
16
33

Leucylglycinamide released from oxytocin by human uterine enzyme.
R Walter, H Shlank, J D Glass, I L Schwartz, T D Kerenyi. Science 1971
147
33

BCPT policy for experimental and clinical studies.
Pernille Tveden-Nyborg, Troels K Bergmann, Niels Jessen, Ulf Simonsen, Jens Lykkesfeldt. Basic Clin Pharmacol Toxicol 2021
53
33

Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex.
Nikhil DeSouza, Steven Reiken, Karol Ondrias, Yi-Ming Yang, Scot Matkovich, Andrew R Marks. J Biol Chem 2002
111
33

Pharmacological Approaches for Treatment-resistant Bipolar Disorder.
Shi Hui Poon, Kang Sim, Ross J Baldessarini. Curr Neuropharmacol 2015
30
33



PP2A as a master regulator of the cell cycle.
Nathan Wlodarchak, Yongna Xing. Crit Rev Biochem Mol Biol 2016
142
33

Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes.
Naina Bhasin, Shane R Cunha, Malkanthi Mudannayake, Marisa S Gigena, Terry B Rogers, Peter J Mohler. Am J Physiol Heart Circ Physiol 2007
70
33

Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients.
Gerome Breen, Adrian J Harwood, Kathryn Gregory, Maggie Sinclair, David Collier, David St Clair, Robin S B Williams. Bipolar Disord 2004
37
33



B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
Gunnar Houge, Dorien Haesen, Lisenka E L M Vissers, Sarju Mehta, Michael J Parker, Michael Wright, Julie Vogt, Shane McKee, John L Tolmie, Nuno Cordeiro,[...]. J Clin Invest 2015
46
33


The effect of prolyl oligopeptidase inhibitors on alpha-synuclein aggregation and autophagy cannot be predicted by their inhibitory efficacy.
Tommi P Kilpeläinen, Laura Hellinen, Johannes Vrijdag, Xu Yan, Reinis Svarcbahs, Kati-Sisko Vellonen, Anne-Marie Lambeir, Henri Huttunen, Arto Urtti, Erik A A Wallen,[...]. Biomed Pharmacother 2020
6
33

GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
Hui Tang, Na Shen, Huijuan Jin, Dan Liu, Xiaoping Miao, Ling-Qiang Zhu. Mol Neurobiol 2013
24
33

PPP2R2B CAG repeat length in the Han Chinese in Taiwan: Association analyses in neurological and psychiatric disorders and potential functional implications.
Chiung-Mei Chen, Yi-Ting Hou, Ju-Yun Liu, Yih-Ru Wu, Chih-Hsin Lin, Hon-Chung Fung, Wen-Chuin Hsu, Yuying Hsu, Shen-Hung Lee, Hsiu-Mei Hsieh-Li,[...]. Am J Med Genet B Neuropsychiatr Genet 2009
17
33


Genomics of Lithium Action and Response.
Benjamin S Pickard. Neurotherapeutics 2017
9
33

IP3 Receptor-Mediated Calcium Signaling and Its Role in Autophagy in Cancer.
Elzbieta Kania, Gemma Roest, Tim Vervliet, Jan B Parys, Geert Bultynck. Front Oncol 2017
65
33

TRPM2, a Susceptibility Gene for Bipolar Disorder, Regulates Glycogen Synthase Kinase-3 Activity in the Brain.
Yongwoo Jang, Sung Hoon Lee, Byeongjun Lee, Seungmoon Jung, Arshi Khalid, Kunitoshi Uchida, Makoto Tominaga, Daejong Jeon, Uhtaek Oh. J Neurosci 2015
30
33


Lithium induces autophagy by inhibiting inositol monophosphatase.
Sovan Sarkar, R Andres Floto, Zdenek Berger, Sara Imarisio, Axelle Cordenier, Matthieu Pasco, Lynnette J Cook, David C Rubinsztein. J Cell Biol 2005
705
33

Regulation of protein kinase cascades by protein phosphatase 2A.
T A Millward, S Zolnierowicz, B A Hemmings. Trends Biochem Sci 1999
656
33

AKT kinase activity is required for lithium to modulate mood-related behaviors in mice.
Jen Q Pan, Michael C Lewis, Josh K Ketterman, Elizabeth L Clore, Misha Riley, Keenan R Richards, Erin Berry-Scott, Xiulin Liu, Florence F Wagner, Edward B Holson,[...]. Neuropsychopharmacology 2011
75
33

Bipolar disorders.
Roger S McIntyre, Michael Berk, Elisa Brietzke, Benjamin I Goldstein, Carlos López-Jaramillo, Lars Vedel Kessing, Gin S Malhi, Andrew A Nierenberg, Joshua D Rosenblat, Amna Majeed,[...]. Lancet 2020
65
33

Inhibition of GSK3 by lithium, from single molecules to signaling networks.
Laure Freland, Jean-Martin Beaulieu. Front Mol Neurosci 2012
155
33

Association between GSK-3beta -50T/C polymorphism and personality and psychotic symptoms in mood disorders.
Alessandro Serretti, Francesco Benedetti, Laura Mandelli, Raffaella Calati, Barbara Caneva, Cristina Lorenzi, Valentina Fontana, Cristina Colombo, Enrico Smeraldi. Psychiatry Res 2008
34
33


Lithium and GADL1 regulate glycogen synthase kinase-3 activity to modulate KCTD12 expression.
Tai-Na Wu, Chih-Ken Chen, Chau-Shoun Lee, Bo-Jian Wu, Hsiao-Ju Sun, Chieh-Hsing Chang, Chun-Ying Chen, Lawrence Shih-Hsin Wu, Andrew Tai-Ann Cheng. Sci Rep 2019
3
33

PP2A-Bgamma subunit and KCNQ2 K+ channels in bipolar disorder.
M Borsotto, L Cavarec, M Bouillot, G Romey, F Macciardi, A Delaye, M Nasroune, M Bastucci, J-L Sambucy, J-J Luan,[...]. Pharmacogenomics J 2007
52
33

Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha.
Noa Kirshenboim, Batya Plotkin, Shani Ben Shlomo, Oksana Kaidanovich-Beilin, Hagit Eldar-Finkelman. J Mol Neurosci 2004
51
33

Gene expression in peripheral blood in treatment-free major depression.
Alfredo B Cuellar-Barboza, Jorge A Sánchez-Ruiz, Iram P Rodriguez-Sanchez, Sarai González, Geovana Calvo, José Lugo, Antonio Costilla-Esquivel, Laura E Martínez, Marisol Ibarra-Ramirez. Acta Neuropsychiatr 2020
2
50

S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies.
Philippe Morain, Pierre Lestage, Guillaume De Nanteuil, Roeline Jochemsen, Jean-Loïc Robin, David Guez, Pierre-Alain Boyer. CNS Drug Rev 2002
88
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.